NCT07381309 2026-02-02
VVSHIP
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2 Not yet recruiting
Clinical Trials
7 trialsNCT07204574 2025-10-02
The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer
Chang Gung Memorial Hospital
Phase 1/2 Recruiting
NCT03336658 2024-11-13
ITB
Insel Gruppe AG, University Hospital Bern
Active not recruiting
NCT05314309 2023-01-11
mtFIT
The Netherlands Cancer Institute
Unknown
NCT05382377 2022-05-19
NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Phase EARLY_PHASE1 Recruiting
NCT03337776 2021-08-05
Effect of WhatsApp Messenger on Uptake of CRC Screening Study
Chinese University of Hong Kong
Phase NA Withdrawn
NCT03601598 2018-07-26
A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC
Harbin Medical University
Phase 1/2 Unknown